StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) shareholders

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)

Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
16.8%
5M of 31M shares
Institutional holders
47
6 new, 12 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ATNMValueChange% of portfolio
Vanguard Capital Management LLC1,238,3023.94%$1.21M−17,2140.00%
Compass Financial Management LLC600,2301.91%$588.23KNew0.07%
Millennium Management LLC514,5801.64%$504.29K−50,0200.00%
Acadian Asset Management LLC496,2881.58%$485.00K−104,5310.00%
BlackRock, Inc.395,8961.26%$387.98K+24,6860.00%
Renaissance Technologies LLC380,4911.21%$372.88K−91,1090.00%
Geode Capital Management, LLC324,9451.03%$318.55K−11,1280.00%
Two Sigma Investments, LP259,1790.82%$254.00K−77,9890.00%
Gagnon Securities LLC182,1420.58%$178.50K−19,1580.03%
Vanguard Fiduciary Trust Co161,5260.51%$158.30K+1,2610.00%
State Street Corp122,2150.39%$119.77K−4,0000.00%
Gen-Wealth Partners Inc105,1110.33%$103.01K−2,0000.03%
Northern Trust Corp69,7430.22%$68.35K−6,1120.00%
Qube Research & Technologies Ltd57,8120.18%$56.66K+39,7640.00%
Susquehanna International Group, Llp56,8220.18%$55.69K−67,1760.00%
Vontobel Holding Ltd.50,0000.16%$49.00K+20,0000.00%
SNS Financial Group, LLC43,0000.14%$42.14KNew0.00%
Bridgeway Capital Management, LLC40,0000.13%$39.20K–0.00%
Am Investment Strategies LLC29,3560.09%$29.00K–0.00%
Gerald Baker Financial Group LLC22,6910.07%$22.24K–0.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026475M16.8%6 / 620 / 121M1M
Q1 2026545M16.9%7 / 1214 / 122M1M
Q4 2025605M17.2%9 / 1319 / 81M0M
Q3 2025615M16.4%9 / 929 / 101M1M
Q2 2025635M17.4%19 / 1122 / 252M4M
Q1 2025698M26.1%10 / 2417 / 91M1M
Q4 2024698M25.9%14 / 2714 / 171M1M
Q3 2024728M26.9%17 / 2419 / 184M1M
Q2 2024747M23.1%19 / 2717 / 111M1M
Q1 2024677M21.9%13 / 1917 / 41M0M
Q4 2023596M18.7%7 / 1818 / 60M0M
Q3 2023586M18.3%4 / 2111 / 160M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

11 funds held ATNM in Q2 2026, 81% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ATNMValue% of fundAs of
Vanguard Total Stock Market Index Fund918,5572.92%$900.19K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund315,3691.00%$309.06K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund171,4470.55%$216.02K0.00%May 31, 2026
iShares Micro-Cap ETF106,7230.34%$104.59K0.01%Jun 30, 2026
Fidelity Total Market Index Fund52,2870.17%$65.88K0.00%May 31, 2026
Fidelity Series Total Market Index Fund44,5300.14%$56.11K0.00%May 31, 2026
Ultra-Small Company Market Fund40,0000.13%$39.20K0.03%Jun 30, 2026
1290 VT Micro Cap Portfolio5,8490.02%$5.73K0.00%Jun 30, 2026
Vanguard Balanced Index Fund4,3760.01%$4.29K0.00%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund3,1140.01%$3.05K0.00%Jun 30, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND1750.00%$1460.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Sandesh SethChief Executive Officer, Director938,0812.98%Sep 4, 2026
Matthew T. DavidChief Financial Officer250,0000.80%Oct 16, 2026
Adeela KamalChief Scientific Officer213,6480.68%Sep 10, 2026
Steffen Wilhem HeegerChief Medical Officer153,8680.49%Sep 10, 2026
Steve O'LoughlinChief Financial Officer35,5000.11%Apr 2, 2025
Richard I. SteinhartDirector63,1160.20%Sep 4, 2026
Nicholson, C. DavidDirector63,3000.20%Sep 4, 2026
June Sherie AlmenoffDirector18,0000.06%Sep 4, 2026
Ajit ShettyDirector62,3570.20%Sep 4, 2026
Jeffrey W. ChellDirector61,6000.20%Sep 4, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Matthew T. David
Chief Financial Officer
Oct 14, 2026Award+250,000––250,000
Sandesh Seth
Chief Executive Officer, Director
Sep 2, 2026Award+753,600––938,081
Sandesh Seth
Chief Executive Officer, Director
Sep 2, 2026Award+1,027,274––1,965,355
June Sherie Almenoff
Director
Sep 2, 2026Award+18,000––18,000
Nicholson, C. David
Director
Sep 2, 2026Award+62,800––63,300
Richard I. Steinhart
Director
Sep 2, 2026Award+62,800––63,116
Ajit Shetty
Director
Sep 2, 2026Award+61,600––62,357
Jeffrey W. Chell
Director
Sep 2, 2026Award+61,600––61,600
Sandesh Seth
Chief Executive Officer, Director
Aug 18, 2025Tax withholding−120,900$1.71$206.74K184,481
Sandesh Seth
Chief Executive Officer, Director
Aug 17, 2022Award+300,000––305,381
Mark Stanley Berger
Chief Medical Officer
Mar 5, 2019Option exercise+3,500$0.60$2.10K22,500
Sandesh Seth
Chairman & CEO, Director
Feb 21, 2019Option exercise+8,125$0.60$4.88K161,458
Sandesh Seth
Chairman & CEO, Director
Dec 10, 2018Buy+10,000$0.44$4.40K153,333
Steve O'Loughlin
Principal Financial Officer
Dec 10, 2018Buy+10,000$0.44$4.40K35,500
Dale L. Ludwig
Chief Scientific Officer
Nov 19, 2018Buy+10,000$0.45$4.50K10,000
Sandesh Seth
CEO, Director
Jul 17, 2018Buy+10,000$0.79$7.90K143,333
Steve O'Loughlin
Principal Financial Officer
Jun 15, 2018Buy+12,000$0.50$6.00K25,500
Sandesh Seth
Chairman & CEO, Director
Apr 19, 2018Buy+5,000$0.38$1.90K133,333
Mark Stanley Berger
Chief Medical Officer
Mar 6, 2018Other+14,000$0.50$7.00K19,000
Nitya G. Ray
Executive VP
Mar 6, 2018Other+10,000$0.50$5.00K20,000
Richard I. Steinhart
Director
Mar 6, 2018Other+7,000$0.50$3.50K9,500
Steve O'Loughlin
Principal Financial Officer
Mar 6, 2018Other+10,000$0.50$5.00K13,500
Sandesh Seth
Chairman & CEO, Director
Mar 6, 2018Other+52,500$0.50$26.25K128,333
Ajit Shetty
Director
Feb 28, 2018Buy+22,730$0.43$9.77K22,730
Nitya G. Ray
Executive Vice President
Aug 2, 2017Buy+10,000$0.75$7.50K10,000
Sandesh Seth
Chairman & CEO, Director
Aug 2, 2017Buy+33,333$0.75$25.00K75,833
Sandesh Seth
Chairman and CEO, Director
Jun 15, 2017Buy+2,500$1.17$2.93K37,500
Sandesh Seth
Chairman and CEO, Director
Jun 15, 2017Buy+5,000$1.16$5.80K42,500
Steve O'Loughlin
Principal Financial Officer
Jun 15, 2017Buy+3,500$1.17$4.10K3,500
Mark Stanley Berger
Chief Medical Officer
Jun 15, 2017Buy+5,000$1.11$5.55K5,000
Sandesh Seth
Executive Chairman, Director
Dec 30, 2016Buy+5,000$0.88$4.40K35,000
Sandesh Seth
Executive Chairman, Director
Dec 12, 2016Buy+5,000$0.98$4.90K30,000
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−14,165$1.87$26.49K4,709,561
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−40,200$1.85$74.37K4,733,526
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−15,000$1.84$27.60K4,773,726
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−800$1.83$1.46K4,788,726
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−25,188$1.80$45.34K4,821,226
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−6,400$1.81$11.58K4,814,826
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−200$1.82$3644,814,626
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−25,100$1.82$45.68K4,789,526
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 31, 2016Sale−9,800$1.86$18.23K4,723,726
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 30, 2016Sale−1,500$1.81$2.72K4,877,488
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 30, 2016Sale−23,500$1.80$42.30K4,878,988
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 30, 2016Sale−30,474$1.81$55.16K4,847,014
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 30, 2016Sale−200$1.81$3624,846,814
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 30, 2016Sale−300$1.82$5464,846,514
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 30, 2016Sale−100$1.82$1824,846,414
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 29, 2016Sale−12,500$1.71$21.38K4,914,988
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 29, 2016Sale−12,500$1.72$21.50K4,902,488
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 26, 2016Sale−12,002$1.71$20.52K4,927,488
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 26, 2016Sale−12,998$1.70$22.10K4,939,490
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 16, 2016Sale−400$1.73$6924,952,488
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 16, 2016Sale−4,629$1.72$7.96K4,952,888
Sloan-Kettering Cancer Center Memorial
10% owner
Aug 15, 2016Sale−4,439$1.72$7.64K4,957,517
Sloan-Kettering Cancer Center Memorial
10% owner
Jul 12, 2016Sale−100$1.81$1814,961,956
Sloan-Kettering Cancer Center Memorial
10% owner
Jul 12, 2016Sale−3,000$1.80$5.40K4,962,056
Sloan-Kettering Cancer Center Memorial
10% owner
Jul 11, 2016Sale−800$1.80$1.44K4,965,056
Sloan-Kettering Cancer Center Memorial
10% owner
Jul 8, 2016Sale−21,190$1.80$38.14K4,965,856
Sloan-Kettering Cancer Center Memorial
10% owner
Jul 6, 2016Sale−10,500$1.80$18.90K4,987,046
Sloan-Kettering Cancer Center Memorial
10% owner
Jul 5, 2016Sale−4,340$1.83$7.94K4,997,546

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
2.01%
1M shares short
Days to cover
1.7
At 0M shares a day
Change since last report
-6.0%
From 1M shares
Short volume, 20 days
35.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Actinium Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,034 shares on Sep 18, 2026 over the last 90 days.

See a number that looks wrong?